semaglutide cancer risk Is Linked to Cancer? What Studies Say Can GLP-1 Drugs Reduce Cancer

The cardiovascular and metabolic benefits of semaglutide and tirzepatide are well-documented and, for many people, life-changing

LB About the author Lucy Brewster Lucy Brewster reports on all things markets and investing for Brew Markets.

But it works best when prescribed appropriately and managed correctly

"GLP-1 stands for glucagon-like peptide-1

Additional warnings include hypoglycemia risk when used with insulin or sulfonylureas, diabetic retinopathy complications in patients with diabetes, and suicidal ideation

Glucagon receptor boosts energy expenditure and fat burning, helping sustain long-term weight reduction